NYSE:BAX - Baxter International Stock Price, Price Target & More

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, May 8th. Shareholders of record on Friday, June 1st will be given a dividend of $0.19 per share on Monday, July 2nd. This represents a $0.76 annualized dividend and a yield of 1.03%. The ex-dividend date of this dividend is Thursday, May 31st. This is a positive change from Baxter International's previous quarterly dividend of $0.16. View Baxter International's Dividend History.

Baxter International declared that its Board of Directors has approved a stock buyback plan on Wednesday, February 21st 2018, which allows the company to buyback $1,500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Shares buyback plans are often an indication that the company's board of directors believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) posted its quarterly earnings data on Thursday, April, 26th. The medical instruments supplier reported $0.70 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.62 by $0.08. The medical instruments supplier had revenue of $2.68 billion for the quarter, compared to analyst estimates of $2.62 billion. Baxter International had a net margin of 7.75% and a return on equity of 15.70%. The firm's quarterly revenue was up 8.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.58 EPS. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Baxter International.

Baxter International issued an update on its FY18 earnings guidance on Thursday, April, 26th. The company provided earnings per share guidance of $2.85-2.93 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.78. The company issued revenue guidance of $11.3-11.4 billion, compared to the consensus revenue estimate of $11.25 billion.Baxter International also updated its Q2 guidance to $0.69-0.71 EPS.

16 analysts have issued 12-month price objectives for Baxter International's stock. Their forecasts range from $62.00 to $83.00. On average, they expect Baxter International's stock price to reach $72.7333 in the next twelve months. This suggests that the stock has a possible downside of 1.4%. View Analyst Ratings for Baxter International.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Baxter International include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), ICU Medical (ICUI), Hill-Rom (HRC), Globus Medical (GMED), Insulet (PODD), Haemonetics (HAE) and Penumbra (PEN).

Media coverage about BAX stock has been trending somewhat positive on Monday, according to Accern. The research group identifies negative and positive press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Baxter International earned a news sentiment score of 0.09 on Accern's scale. They also assigned news stories about the medical instruments supplier an impact score of 48.13 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

Baxter International's stock is owned by many different of institutional and retail investors. Top institutional investors include Bank of Montreal Can (0.11%), Gateway Investment Advisers LLC (0.08%), NN Investment Partners Holdings N.V. (0.05%), Gulf International Bank UK Ltd (0.03%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.03%) and Handelsbanken Fonder AB (0.03%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Bank of Montreal Can, Gateway Investment Advisers LLC, CenturyLink Investment Management Co, Ledyard National Bank, BLB&B Advisors LLC, First Citizens Bank & Trust Co. and Legacy Private Trust Co.. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was bought by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, Gulf International Bank UK Ltd, State of Alaska Department of Revenue, Fjarde AP Fonden Fourth Swedish National Pension Fund, IFM Investors Pty Ltd, DnB Asset Management AS, Xact Kapitalforvaltning AB and Mitchell Sinkler & Starr PA. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $73.79.

Baxter International has a market capitalization of $40.04 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]